CPI-refractory melanomaCPI-refractory diseasemelanomapembrolizumabICT01ICT01-pembrolizumabICT01-mediated
…zumab generated clinically meaningful anti-tumor efficacy in 2L CPI-refractory melanoma patients, indicating the potential to overcome resistance to ch…